Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-08

Clinical Trial Update: Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia [NA]

View source ↗

Summary

Completed clinical trial evaluating exenatide as a diagnostic test for endogenous Hyperinsulinism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Endogenous Hyperinsulinism | NA | Status: COMPLETED